Abstract Library

#4202 Preliminary experience with a new institutional dedicated neuroendocrine team in a tertiary

Introduction: Due to the complexity of neuroendocrine neoplasm (NEN) management, a multidisciplinary approach is strongly encouraged. At our institution, tertiary care center, a NEN Team was established in January 2021.

Conference:

Presenting Author: Smiroldo V

Authors: Smiroldo V, Bollina R, de Nucci G, Della Torre S,

Keywords: tertiary care center, multidisciplinary, NEN team,

#4193 Pivotal role of the multidisciplinary tumor board on the management of neuroendocrine neoplasms – Impact of MTB decisions in an ENETS Center of Excellence

Introduction: Multidisciplinary Tumor Board (MTB) meetings are a valuable tool to improve the management of solid tumors. Yet, few evidences regarding the real-world impact of Neuroendocrine Neoplasm (NEN)-dedicated MTBs are available.

Conference:

Presenting Author:

Authors: Maratta M, Vitale A, Occhipinti D, Raia S, Menotti S,

Keywords: multidisciplinary tumor board, neuroendocrine cancer, disease management, patient care,

#4050 PET/CT imaging of the somatostatin receptor with [18F]AlF-NOTA-octreotide PET/CT: Analysis of impact on tumor staging and therapeutic management

Introduction: [18F]AlF-NOTA-octreotide ([18F]AlF-OC) is a promising alternative for [68Ga]Ga-DOTA-somatostatin analogues (SSAs) in PET imaging of the somatostatin receptor (SST).

Conference:

Presenting Author: Leupe H

Authors: Leupe H, Vandamme T, van den Broeck B, Lybaert W, Dekervel J,

Keywords: Neuroendocrine tumor, nuclear medicine, PET imaging, somatostatin receptor, [68Ga]Ga-DOTA-SSA, [18F]AlF-NOTA-octreotide,

#3846 Poorly differentiated neuroendocrine carcinomas – Characteristics, treatments and outcomes from a population-based cohort discussed in our ENETS-CoE institute

Introduction: Poorly differentiated neuroendocrine carcinomas (NECs) are rare malignancies with a dismal prognosis, few therapeutic options available and lacking predictive factors.

Conference:

Presenting Author: Benini L

Authors: Benini L, Spada F, Gervaso L, Borghesani M, Rubino M,

Keywords: Neuroendocrine Carcinoma, NEC,

#3357 Sars-Cov-2 pandemic and PRRT: The experience of European Institute of Oncology (IEO), Milano, Italy

Introduction: The importance of timely assistance in oncological patients is undeniable; however it is well known that these patients could have important clinical problems if they were infected by COVID-19, with an increased risk of severe illness and mortality. A recent multicenter Italian study reported a delay both in the beginning of PRRT for new patients and in those ones who had already started the treatment, as a direct consequence of COVID-19.

Conference:

Presenting Author: Grana C

Authors: Grana C, Fazio N, Spada F, Rocca P, Laffi A,

Keywords: PRRT, GEP-NET, COVID-19,